Multimodal Molecular Imaging Technology Accelerates Drug Discovery

A new multispectral imaging system is designed to enable researchers to precisely locate and monitor changes in molecular activity of specific areas of interest--long before morphologic changes can be detected--expediting the development of effective therapeutics for disease treatment.

The Kodak In Vivo multispectral imaging system FX, developed by Carestream Molecular Imaging (Rochester, NY, USA), enables life-science researchers to pursue a research path for a particular disease or therapeutic from in vitro to in vivo applications--moving from specimen to "live” in vivo studies using advanced software capable of analyzing and comparing many different types of molecular applications. Currently, it is the only instrument that provides multispectral fluorescence, luminescence, digital X-ray, and radioisotopic imaging capabilities for in vivo (small animal) imaging.

The Kodak Multispectral imaging system earned the "Top 10 Innovations of 2008” award from The Scientist magazine. A panel of expert judges evaluated a broad range of life-science technologies to determine the year's top innovations, with the winners were released in the publication's December 2008 issue.

"Our Multispectral system is the culmination of several years of research and development," said Bill McLaughlin, director of research and advanced applications, Carestream Molecular Imaging. "This honor is a tribute not only to our scientists and engineers, who are committed to advancing the knowledge of molecular imaging, but also to our customers--the researchers demanding these advances to allow them to perform incredibly powerful applications.”

Related Links:
Carestream Molecular Imaging